Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise
In the US , its approved to help reduce and maintain weight (with diet + exercise) in adults with obesity or overweight (with related conditions), and also to reduce major cardiovascular event risk in certain adults with heart disease and obesity/overweight
Most commonly, people can experience gastrointestinal symptoms, mainly nausea
Recent large-scale studies have provided significant reassurance
Results showed that people on Medicaid or Medicare, Black patients and those experiencing nausea or other GI side effects were more likely to quit their GLP-1 drug
For couples: Many couples explore PT-141 together it can be a thoughtful way to address differences in desire that affect intimacy
